OpportunityTitle: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications
AdditionalInformationOnEligibility: This announcement is for revision applications to active NIH Research Grants, including, but not limited to, R01, R03, R15, R21, R25, R33, R34, R37, R21/R33, R41, R42, R43, R44, SC1, SC2, SC3 grants, and Program Project grants, Center grants, Cooperative Agreements, Training Grants, and Institutional Career Development Awards. Recognize that these are 2-year awards and probably are most appropriate at the post-doctoral level. (Note: Most Ks and Ts are eligible for administrative supplements [see NOT-OD-09-056].) Individual Institutes and Centers (ICs) have more detailed eligibility information on their own Web sites. See http://grants.nih.gov/recovery/ic_supp.html.    Fellowships (Fs) and Conference Grants (R13s) will not be considered for revisions.    See instructions in the full announcement to determine appropriate application forms and submission process.    Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: The National Institutes of Health (NIH) announces the opportunity for investigators and United States institutions/organizations with active NIH-supported research project grants (including SBIR and STTR) to submit revision applications (formerly termed competitive supplements) to support a significant expansion of the scope or research protocol of approved and funded projects. Support for these revision applications will come from funds provided to NIH through the American Recovery and Reinvestment Act of 2009 (&#147;Recovery Act&#148; or &#147;ARRA&#148;), Public Law 111-5. In addition, Recovery Act funds allocated to NIH specifically for comparative effectiveness research (CER) may be available to support supplements. Projects receiving these funds will need to meet this definition of CER: &#147;a rigorous evaluation of the impact of different options that are available for treating a given medical condition for a particular set of patients. Such a study may compare similar treatments, such as competing drugs, or it may analyze very different approaches, such as surgery and drug therapy.&#148; Such research may include the development and use of clinical registries, clinical data networks, and other forms of electronic health data that can be used to generate or obtain outcomes data as they apply to CER. This announcement is one of three ARRA administrative supplement/competitive revision notices issued by NIH. Approximately $1 billion of ARRA funds will be obligated by September 30, 2010 to support requests submitted in response to these three notices or any reissuance of these notices. Funding decisions and awards will be issued on or prior to September 30, 2009 for applications submitted in response to this notice, and on or prior to September 30, 2010 for applications submitted in response to any reissuance of this notice. The deadline for receipt of these revision applications is April 21, 2009. Resubmissions will only be accepted if this notice is reissued.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster